Lucid Diagnostics Inc. Common Stock
XNAS:LUCD
1.06
$1.07 - 47.00
$1.05 - 300.00
$1.05
$1.1
$1.06
$1.07
1.8
0.75
387002
715970.8
98764559.44
Chart
TendieTensor AI Analysis
Company
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Fundamentals
70
-1.180000
-4.879800
-0.1
100
BBG012NYMLC0
BBG012NYMM65
137.23M
130.64M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own LUCD. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.